6-[2-(4-methylanilino)acetyl]-4H-1,4-benzoxazin-3-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 6-[2-(4-methylanilino)acetyl]-4H-1,4-benzoxazin-3-one
• 化学式: C₁₇H₁₆N₂O₃
• 分子量: 296.32
• InChiKey: DBXDOUQXKOSHLB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  67.4
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Benzoxazinone derivatives for use in the treatment of angiogenesis
  申请人：——

  公开号：US20040122006A1

  公开（公告）日：2004-06-24

  This invention relates to novel compounds of Formula (I) for use as vascular damaging agents: wherein: X is selected from: —O—, —S—, —S(O)—, —S(O 2 )—, —N(R 4 )— or —N(R 4 )CH 2 C(O)—; R 1 is independently selected from: amino, halo, hydroxy, —OPO 3 H 2 , C 1-4 alkyl, C 1-4 alkoxy, N—C 1-4 alkylamino, N,N-di-C 1-4 alkylamino, C 1-4 alkanoylamino or C 1-4 alkylthio wherein the amino group is optionally substituted by an amino acid residue and the hydroxy group is optionally esterified; R 2 is selected from: hydrogen or C 1-4 alkyl; R 3 is selected from: hydrogen or C 1-4 alkyl; R 4 is selected from: hydrogen or C 1-4 alkyl; n is 0, 1 or 2; and p is 0, 1, 2 or 3; or a salt, pro-drug or solvate thereof. The invention also relates to methods for preparing compounds of Formula (I), to their use as medicaments (including methods for the treatment of angiogenesis or disease states associated with angiogenesis) and to pharmaceutical compositions containing compounds of Formula (I). 1

  本发明涉及一种新型化合物（I）用作血管损伤剂：其中：X选自：—O—，—S—，—S（O）—，—S（O2）—，—N（R4）—或—N（R4）CH2C（O）—；R1独立选择自：氨基，卤素，羟基，—OPO3H2，C1-4烷基，C1-4烷氧基，N- C1-4烷基氨基，N，N-二C1-4烷基氨基，C1-4烷酰胺基或C1-4烷基硫醇，其中氨基团可选择性地被氨基酸残基取代，羟基团可选择性酯化；R2选自：氢或C1-4烷基；R3选自：氢或C1-4烷基；R4选自：氢或C1-4烷基；n为0，1或2；p为0，1，2或3；或其盐，前药或溶剂。本发明还涉及制备化合物（I）的方法，它们用作药物（包括用于治疗血管生成或与血管生成相关的疾病状态的方法），以及含有化合物（I）的制药组合物。
• EP1385835A1
  申请人：——

  公开号：EP1385835A1

  公开（公告）日：2004-02-04
• US6951855B2
  申请人：——

  公开号：US6951855B2

  公开（公告）日：2005-10-04
• [EN] BENZOXAZINONE DERIVATIVES FOR USE IN THE TREATMENT OF ANGIOGENESIS<br/>[FR] DERIVES DE BENZOXAZINONE POUR LE TRAITEMENT DE L'ANGIOGENESE
  申请人：ASTRAZENECA AB

  公开号：WO2002085868A1

  公开（公告）日：2002-10-31

  This invention relates to novel compounds of Formula (I) for use as vascular damaging agents: wherein: X is selected from: -O-, -S-, -S(O)-, -S(O2)-, -N(R4)- or -N(R4)CH2C(O)-; R1 is independently selected from: amino, halo, hydroxy, -OPO3H2, C1-4alkyl, C1-4alkoxy, N-C1-4alkylamino, N,N-di-C1-4alkylamino, C1-4alkanoylamino or C1-4alkylthio wherein the amino group is optionally substituted by an amino acid residue and the hydroxy group is optionally esterified; R2 is selected from: hydrogen or C1-4alkyl; R3 is selected from: hydrogen or C1-4alkyl; R4 is selected from: hydrogen or C1-4alkyl; n is 0, 1 or 2; and p is 0, 1, 2 or 3; or a salt, pro-drug or solvate thereof. The invention also relates to methods for preparing compounds of Formula (I), to their use as medicaments (including methods for the treatment of angiogenesis or disease states associated with angiogenesis) and to pharmaceutical compositions containing compounds of Formula (I).